Despite national efforts, cancer clinical trials are becoming less diverse, study finds

In the U.S., millions of people experience cancer every year, but don’t have an equal opportunity to access experimental treatments in clinical trials, or to receive treatments that have been shown to be effective in patients like them.

This post was originally published on this site